Trial Profile
Phase II Trial: uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Feb 2023
Price :
$35
*
At a glance
- Drugs Gallium-68 NOTA AE105 (Primary)
- Indications Mouth neoplasm; Oropharyngeal cancer
- Focus Diagnostic use
- 03 Oct 2016 New trial record